NeuroPace, Inc. (NPCE) Stock
Healthcare · Medical Devices · Member of Other US Stocks
NeuroPace, Inc. (NPCE) closed at USD 12.56 on 2026-10-14, a change of +18.3 % over the past year, with a market capitalization of USD 438.66M.
NeuroPace, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 12.56 |
| 2026-10-13 | 12.68 |
| 2026-10-12 | 13.00 |
| 2026-10-09 | 12.67 |
| 2026-10-08 | 12.39 |
| 2026-10-07 | 12.76 |
| 2026-10-06 | 12.67 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
NeuroPace, Inc. key figures
- Previous close
- USD 12.56 (2026-10-14)
- 1-year change
- +18.3 %
- Market cap
- USD 438.66M
- Enterprise value
- USD 456.9M
- P/E ratio (trailing)
- -22.42
- P/E ratio (forward)
- -58.76
- EPS (trailing)
- -0.57
- EPS (forward)
- -0.22
- PEG ratio
- n/a
- Price to book
- 36.83
- Revenue growth
- 17.1 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 6.86
- Employees
- 220
- Analyst consensus (third-party)
- strong_buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for NeuroPace, Inc. and compare it with other stocks.
Analyze NPCEAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell NeuroPace, Inc. shares.